IL6 and diabetes mellitus: Table 2 shows summary statistics in each cohort. There were significant differences in the distributions of few variables based on availability of inflammatory lab data. The most relevant differences were lower prevalence of diabetes among those with IL6 measurements (p<0.0001), younger age among those with LpPLA2 mass and activity levels (p<0.0001), and higher prevalence of Medicaid or no insurance and diabetes among those with LpPLA2 mass and activity levels (p<0.0001 and p = 0.0001 respectively). The S1 Table lists the distribution of BI assessments over follow-up.